Medicare Enrolled
Dr. Saad Amin, MD
Internal Medicine · Asheboro, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amin
Dr. Saad Amin is an internal medicine specialist in Asheboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Amin performed 1,091 Medicare services across 416 unique beneficiaries.
Between the years covered by Open Payments, Dr. Amin received a total of $8,647 from 64 pharmaceutical and/or device companies across 541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in NC
$8,647 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,091
Medicare services
Top 30% in NC for internal medicine
416
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~55 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
406 | $60 | $121 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
143 | $90 | $144 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
135 | $81 | $146 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
111 | $8 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
90 | $58 | $117 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
56 | $99 | $205 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
38 | $138 | $262 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
19 | $30 | $35 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $132 | $280 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
18 | $29 | $30 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
16 | $122 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $71 | $160 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
13 | $2 | $13 |
| Annual depression screening | 12 | $17 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,647
Total received (2018-2024)
Avg $1,235/year across 7 years
Top 11% in NC for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
541
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,647 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,248
2023
$959
2022
$1,203
2021
$1,795
2020
$962
2019
$1,452
2018
$1,028
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$274
Novo Nordisk Inc
$198
AstraZeneca Pharmaceuticals LP
$146
Lilly USA, LLC
$133
GlaxoSmithKline, LLC.
$65
Amgen Inc.
$65
Bayer Healthcare Pharmaceuticals Inc.
$50
Biogen, Inc.
$49
Eisai Inc.
$40
PFIZER INC.
$39
Xeris Pharmaceuticals, Inc.
$36
SHIELD THERAPEUTICS INC
$34
Vifor Pharma, Inc.
$25
Kiniksa Pharmaceuticals International, plc
$23
IDORSIA PHARMACEUTICALS US INC
$22
Mylan Specialty L.P.
$18
Merck Sharp & Dohme LLC
$16
Edwards Lifesciences Corporation
$16
Top 3 companies account for 49.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,088
AstraZeneca Pharmaceuticals LP
$912
Lilly USA, LLC
$730
Amgen Inc.
$438
ABBVIE INC.
$433
Sunovion Pharmaceuticals Inc.
$427
SANOFI-AVENTIS U.S. LLC
$397
Novartis Pharmaceuticals Corporation
$337
AbbVie Inc.
$296
Avanir Pharmaceuticals, Inc.
$215
PFIZER INC.
$190
GlaxoSmithKline, LLC.
$185
Bayer HealthCare Pharmaceuticals Inc.
$154
Eisai Inc.
$139
Bayer Healthcare Pharmaceuticals Inc.
$137
Amarin Pharma Inc.
$134
Janssen Pharmaceuticals, Inc
$111
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
Esperion Therapeutics, Inc.
$106
Alexion Pharmaceuticals, Inc.
$92
Corium, LLC
$87
Arbor Pharmaceuticals, Inc.
$85
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$85
ARBOR PHARMACEUTICALS, INC.
$84
Xeris Pharmaceuticals, Inc.
$82
Kowa Pharmaceuticals America, Inc.
$77
Biohaven Pharmaceuticals, Inc.
$75
Takeda Pharmaceuticals U.S.A., Inc.
$74
Sumitomo Pharma America, Inc.
$74
Merck Sharp & Dohme LLC
$73
Merck Sharp & Dohme Corporation
$70
Teva Pharmaceuticals USA, Inc.
$65
Biogen, Inc.
$64
Biohaven Pharmaceutical Holding Company Ltd.
$62
Astellas Pharma US Inc
$61
Vifor Pharma, Inc.
$61
IDORSIA PHARMACEUTICALS US INC
$56
Daiichi Sankyo Inc.
$54
EISAI INC.
$50
Ironwood Pharmaceuticals, Inc
$49
AbbVie, Inc.
$48
NeoTract Inc.
$48
Otsuka America Pharmaceutical, Inc.
$48
Vanda Pharmaceuticals Inc.
$41
Nestle HealthCare Nutrition Inc.
$39
SHIELD THERAPEUTICS INC
$34
Purdue Pharma L.P.
$30
Mylan Specialty L.P.
$30
ACADIA Pharmaceuticals Inc
$28
Neurocrine Biosciences, Inc.
$27
Allergan Inc.
$25
Allergan, Inc.
$24
Kiniksa Pharmaceuticals International, plc
$23
Abbott Laboratories
$22
Lundbeck LLC
$22
Ultragenyx Pharmaceutical Inc.
$20
Collegium Pharmaceutical, Inc.
$17
SCILEX PHARMACEUTICALS INC.
$16
Edwards Lifesciences Corporation
$16
Exact Sciences Corporation
$15
CMP Pharma, Inc.
$14
Genentech USA, Inc.
$14
BioDelivery Sciences International, Inc.
$14
DEXCOM, INC.
$13
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · ADUHELM · AJOVY · ANORO · ANORO ELLIPTA · APTIOM · AUSTEDO · AVYCAZ · Adlarity · Aimovig · Arcalyst · BASAGLAR · BELBUCA · BELSOMRA · BREZTRI · BRILINTA · BYDUREON · Belviq · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CaroSpir · Cologuard Collection Kit · Creon · DEXCOM G6 TRANSMITTER · Dayvigo · Dymista · EMGALITY · ENTRESTO · EVENITY · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FreeStyle Libre 2 · GARDASIL · GATTEX · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · Horizant · INGREZZA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQEMBI · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Leqembi · Linzess · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Morphabond ER · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · Prolia · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RYBELSUS · Repatha · Rybelsus · SKYCLARYS · SOLIQUA · SOLIQUA 100/33 · SYMBICORT · SYMPROIC · Saxenda · Strensiq · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · UBRELVY · UTIBRON NEOHALER · UroLift · Utibron · VERQUVO · VRAYLAR · Vascepa · Veltassa · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xofluza · Xultophy 100/3.6 · YUPELRI · ZENPEP · ZERBAXA · ZTLido · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
262
Per 100K population
180.3
County median income
$59,047
Nearest hospital
RANDOLPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amin is a clinical cardiology specialist, with above-average Medicare volume (top 30% in NC), with low-engagement industry engagement in the top 11% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amin experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Amin performed 406 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amin receive payments from pharmaceutical companies?
Yes. Dr. Amin received a total of $8,647 from 64 companies across 541 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amin's costs compare to other internal medicine physicians in Asheboro?
Dr. Amin's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Asheboro
Browse internal medicine physicians in Asheboro ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NC
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NC
Which NC internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology